Skip to content

Evaluating Interventions for Alcohol Use Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02409888
Enrollment
140
Registered
2015-04-07
Start date
2015-11-30
Completion date
2021-07-31
Last updated
2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism

Brief summary

The purpose of this study is to investigate how behavioral treatments for alcohol use disorders affect behavior change.

Interventions

BEHAVIORALMotivational Enhancement Therapy

The motivational enhancement therapy will be delivered according to the Project MATCH manual.

BEHAVIORALCognitive Behavioral Therapy

The cognitive behavioral therapy will be delivered according to the Project MATCH manual.

OTHERFC Assessment

FC Assessment study participants are exposed to quarterly assessments across broad domains of functioning.

OTHERIB Assessment

IB Assessment study participants are exposed to semi-annual alcohol specific assessments

Sponsors

Syracuse University
CollaboratorOTHER
Pacific Institute for Research and Evaluation
CollaboratorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Study inclusion criteria are such that study participants must: 1. meet a Diagnostic and Statistical Manual-IV (DSM-IV) alcohol abuse or dependence diagnosis based on the Diagnostic Interview Schedule - IV (DIS-IV); 2. consume a weekly average of at least 24 standard drinks during the baseline period to include at least 5 episodes of heavy drinking; 3. agree not to seek additional alcohol or other substance abuse treatment during the study period; 4. be at least 18 years of age; and 5. be sufficiently proficient in their English speaking ability to interact effectively with the research interviewer.

Exclusion criteria

* Individuals assessed as having a drug diagnosis that is more severe than their alcohol diagnosis (e.g., cocaine dependence and alcohol abuse, IV drug use), * a serious psychiatric diagnosis (e.g., uncontrolled schizophrenia or major depression) as well as those meeting criteria for organic brain impairment, as measured by the mini-mental status examination section of the DIS-IV will be precluded from study participation. In addition, * individuals reporting current enrollment in a substance abuse treatment program, * mandated to substance abuse treatment by a court order, or * severely socially unstable (e.g., homeless) also will be precluded from study participation.

Design outcomes

Primary

MeasureTime frameDescription
Alcohol UseOne year post-treatmentAlcohol use will be measured as percent days abstinent, mean drinks per drinking day, and percent heavy drinking days for study months 3 - 15 (one year post-treatment).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026